NEI
ONC

Northwest & Ethical Investments’s BeOne Medicines Ltd ONC Stock Holding History

Northwest & Ethical Investments’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-5,113
Closed -$1.46M – 420
2020
Q3 		$1.46M Buy
5,113
+905
+22% +$213K 0.06% 269
2020
Q2 		$793K Buy
4,208
+671
+19% +$109K 0.04% 318
2020
Q1 		$435K Sell
3,537
-3,388
-49% -$530K 0.03% 337
2019
Q4 		$1.15M Sell
6,925
-2,156
-24% -$358K 0.05% 309
2019
Q3 		$1.11M Buy
9,081
+354
+4% +$47K 0.05% 306
2019
Q2 		$1.08M Hold
8,727
– – 0.05% 311
2019
Q1 		$1.15M Sell
8,727
-1,374
-14% -$185K 0.06% 301
2018
Q4 		$1.42M Buy
10,101
+5,739
+132% +$761K 0.08% 281
2018
Q3 		$751K Buy
4,362
+1,644
+60% +$276K 0.05% 308
2018
Q2 		$418K Buy
+2,718
New +$485K 0.03% 313

Other funds holding ONC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Northwest & Ethical Investments's ONC Position: Q4 2020 in Review

Northwest & Ethical Investments sold out of BeOne Medicines Ltd (ONC) in Q4 2020, closing a stake of 5,113 shares — an estimated $1.46M sold.

Northwest & Ethical Investments first reported a position in ONC in Q2 2018 and held it in 10 quarters. The position peaked at $1.46M in Q3 2020. 247 funds tracked by Wall St. Rank hold ONC as of Q4 2020.

  • Northwest & Ethical Investments reported no remaining BeOne Medicines Ltd position as of Q4 2020 after selling out during the quarter.
  • Northwest & Ethical Investments sold 5,113 BeOne Medicines Ltd shares in Q4 2020, an estimated $1.46M.
  • Northwest & Ethical Investments first reported a position in BeOne Medicines Ltd in Q2 2018 and held it in 10 quarters.
  • Northwest & Ethical Investments's BeOne Medicines Ltd position peaked at $1.46M in Q3 2020.
  • 247 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q4 2020.

Based on Northwest & Ethical Investments's 13F filing for Q4 2020, filed 8 Jul 2025.